The Trump administration recently announced a trade deal with the United Kingdom that could pay dividends for patients on ...

AI is lowering barriers to CBRN threats—but with coordinated public-private partnerships, the same technologies can become ...

"FDA and EMA release collaborative AI framework for drug development" was originally created and published by Pharmaceutical ...

Pharmaceutical companies are paying thousands of Indiana doctors to talk about GLP-1 drugs, a WRTV Investigation has ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

Antibiotics (ABs) are among the most used pharmaceutical drugs worldwide, as they are currently the most effective medicines ...

Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, ...

The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest ...

Cambridge, Massachusetts, January 14, 2025 - Insilico Medicine (“Insilico”, HKEX:03696), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

“Early personalization is often discussed as an enhancement rather than as a structural element of launch design,” said Emily ...

The growing complexity of pharmaceutical and biotech innovation has placed unprecedented pressure on life science recruiters ...